{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:50:14Z","timestamp":1782625814788,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673674"],"award-info":[{"award-number":["81673674"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7132150"],"award-info":[{"award-number":["7132150"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejphar.2022.175115","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T20:24:29Z","timestamp":1655756669000},"page":"175115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3"],"prefix":"10.1016","volume":"929","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175115_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2022.175115_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.redox.2017.09.009","article-title":"Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration","volume":"14","author":"Bartesaghi","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2022.175115_bib3","first-page":"1","article-title":"Protective effect of aminoguanidine against lipopolysaccharide-induced hepatotoxicity and liver dysfunction in rat","author":"Beheshti","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175115_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14466","article-title":"Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis","author":"Bossen","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2022.175115_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cld.2019.06.004","article-title":"Pharmacologic management of portal hypertension","volume":"23","author":"Bunchorntavakul","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2022.175115_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2022.175115_bib9","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3748\/wjg.v26.i21.2810","article-title":"Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation","volume":"26","author":"Du","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2022.175115_bib10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","article-title":"CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis","volume":"63","author":"Ehling","year":"2014","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2022.175115_bib11","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0891-5849(03)00275-2","article-title":"Extracellular superoxide dismutase in biology and medicine","volume":"35","author":"Fattman","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2022.175115_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2010.07.034","article-title":"Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"54","author":"Garcia-Caldero","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","author":"Garcia-Pagan","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/hep.22166","article-title":"Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability","volume":"47","author":"Gracia-Sancho","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2022.175115_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.04.033","article-title":"Danger signals in liver injury and restoration of homeostasis","author":"Han","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcma.2014.10.004","article-title":"Molecular mechanisms of circulatory dysfunction in cirrhotic portal hypertension","volume":"78","author":"Ho","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ejphar.2022.175115_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","article-title":"Pathophysiology of portal hypertension","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2022.175115_bib19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100316","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Reports"},{"key":"10.1016\/j.ejphar.2022.175115_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2005.10.004","article-title":"Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis","volume":"44","author":"Langer","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/gut.2008.149880","article-title":"Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension","volume":"58","author":"Lavina","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2022.175115_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2022.175115_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0009-8981(82)90360-6","article-title":"Superoxide dismutase in extracellular fluids","volume":"126","author":"Marklund","year":"1982","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2022.175115_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.freeradbiomed.2021.01.027","article-title":"Superoxide dismutase 3 is expressed in bone tissue and required for normal bone homeostasis and mineralization","volume":"164","author":"Matthiesen","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2022.175115_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0003-9861(77)90386-1","article-title":"Superoxide dismutase and peroxidase: a positive activity stain applicable to polyacrylamide gel electropherograms","volume":"183","author":"Misra","year":"1977","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2022.175115_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4939-7837-3_23","article-title":"Depleting macrophages in vivo with clodronate-liposomes","volume":"1784","author":"Moreno","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2022.175115_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147662","article-title":"Glycyrrhizin attenuates portal hypertension and collateral shunting via inhibition of extrahepatic angiogenesis in cirrhotic rats","volume":"22","author":"Pun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.175115_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.trsl.2007.10.003","article-title":"Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD","volume":"151","author":"Qin","year":"2008","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2022.175115_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2020.00354","article-title":"Systemic MCP-1 levels derive mainly from injured liver and are associated with complications in cirrhosis","volume":"11","author":"Queck","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2022.175115_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6699560","article-title":"Exploring the pivotal immunomodulatory and anti-inflammatory potentials of glycyrrhizic and glycyrrhetinic acids","volume":"2021","author":"Richard","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2022.175115_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2006.11.008","article-title":"Potential role of antioxidants in the treatment of portal hypertension","volume":"46","author":"Rodriguez-Vilarrupla","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2015.05.008","article-title":"Arachidonic acid metabolites and endothelial dysfunction of portal hypertension","volume":"120","author":"Sacerdoti","year":"2015","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2022.175115_bib34","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/apt.13618","article-title":"The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis","volume":"43","author":"Sandahl","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175115_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0973-6883(11)60127-8","article-title":"Pathophysiology of portal hypertension and its clinical links","volume":"1","author":"Seo","year":"2011","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ejphar.2022.175115_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(89)90178-6","article-title":"The liposome-mediated macrophage \u201csuicide\u201d technique","volume":"124","author":"Van Rooijen","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2022.175115_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-60327-360-2_13","article-title":"Liposomes for specific depletion of macrophages from organs and tissues","volume":"605","author":"van Rooijen","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2022.175115_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-60327-360-2_13","article-title":"Liposomes for specific depletion of macrophages from organs and tissues","volume":"605","author":"van Rooijen","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2022.175115_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00318625","article-title":"Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate","volume":"260","author":"Van Rooijen","year":"1990","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2022.175115_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(03)73001-8","article-title":"In vivo\u201d depletion of macrophages by liposome-mediated \u201csuicide","volume":"373","author":"van Rooijen","year":"2003","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2022.175115_bib41","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","article-title":"The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair","volume":"89","author":"Vollmar","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2022.175115_bib42","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2013.01.005","article-title":"Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis","volume":"58","author":"Waidmann","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.175115_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.intimp.2004.10.016","article-title":"Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs","volume":"5","author":"Zardi","year":"2005","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2022.175115_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0891-5849(02)00905-X","article-title":"Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression","volume":"33","author":"Zelko","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2022.175115_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3748\/wjg.v18.i5.472","article-title":"A pharmacodynamic model of portal hypertension in isolated perfused rat liver","volume":"18","author":"Zhang","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2022.175115_bib46","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.3748\/wjg.v19.i36.6069","article-title":"Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis","volume":"19","author":"Zhao","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2022.175115_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2017.04.025","article-title":"Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats","volume":"807","author":"Zhao","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175115_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prostaglandins.2006.05.005","article-title":"Peroxynitrite and protein tyrosine nitration of prostacyclin synthase","volume":"82","author":"Zou","year":"2007","journal-title":"Prostag. Other Lipid Mediat."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:05:27Z","timestamp":1757977527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922003764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":48,"alternative-id":["S0014299922003764"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175115","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175115"}}